Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.
<h4>Objective</h4>Alzheimer disease (AD) is a progressive, degenerative and irreversible neurological disorder with few therapies available. In search for new potential targets, increasing evidence suggests a role for the endocannabinoid system (ECS) in the regulation of neurodegenerativ...
Enregistré dans:
Auteurs principaux: | Claudio D'Addario, Andrea Di Francesco, Beatrice Arosio, Cristina Gussago, Bernardo Dell'Osso, Monica Bari, Daniela Galimberti, Elio Scarpini, A Carlo Altamura, Daniela Mari, Mauro Maccarrone |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/356f64993bd64394bf1b45b7d3c01d4d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease
par: Francesca La Rosa, et autres
Publié: (2021) -
Ten-year outcome of vagus nerve stimulation-implanted patients with treatment-resistant depression: two Italian cases
par: Dell'Osso B, et autres
Publié: (2018) -
Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats.
par: K Yaragudri Vinod, et autres
Publié: (2012) -
The Inhibition of the Degrading Enzyme Fatty Acid Amide Hydrolase Alters the Activity of the Cone System in the Vervet Monkey Retina
par: Joseph Bouskila, et autres
Publié: (2021) -
Genetic Variants of Fatty Acid Amide Hydrolase Modulate Acute Inflammatory Responses to Colitis in Adult Male Mice
par: Haley A. Vecchiarelli, et autres
Publié: (2021)